A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Public ClinicalTrials.gov record NCT07191483. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of KYN-5356 as Adjunctive Treatment in Adults With Cognitive Impairment Associated With Schizophrenia
Study identification
- NCT ID
- NCT07191483
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Kynexis B.V.
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Interventions
- KYN-5356 High Dose Drug
- KYN-5356 Medium Dose Drug
- KYN-5356 low dose Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 26, 2025
- Primary completion
- Sep 30, 2025
- Completion
- Nov 30, 2026
- Last update posted
- Sep 24, 2025
2025 – 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Woodland International Research Group | Little Rock | Arkansas | 72211 | Recruiting |
| Synergy Research Center | Lemon Grove | California | 92064 | Recruiting |
| Cenexel CNS | Los Alamitos | California | 90720 | Recruiting |
| Cenexel RCA | Hollywood | Florida | 33024 | Recruiting |
| Segal Trials | Miami Lakes | Florida | 33016 | Recruiting |
| Cenexel ACMR | Atlanta | Georgia | 30331 | Recruiting |
| Cenexel iResearch Atlanta | Decatur | Georgia | 30030 | Recruiting |
| Uptown Research Institute | Chicago | Illinois | 60640 | Recruiting |
| Cenexel CBH | Gaithersburg | Maryland | 20877 | Recruiting |
| Arch Clinical Trials | St Louis | Missouri | 63125 | Recruiting |
| Cenexel HRI | Marlton | New Jersey | 08053 | Recruiting |
| Neuro-Behavioral Clinical Research | North Canton | Ohio | 44720 | Recruiting |
| Community Clinical Research | Austin | Texas | 78754 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07191483, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07191483 live on ClinicalTrials.gov.